跳至主要内容
临床试验/ISRCTN17054996
ISRCTN17054996已完成未知

Comparative Evaluation of QUEtiapine-Lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in people with bipolar depression

niversity of Oxford (UK)0 个研究点目标入组 202 人开始时间: 2008年2月29日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
202

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • For the active run-in phase:
  • 1. Primary diagnosis of bipolar disorder type I or II (based on Diagnostic and Statistical Manual of Mental Disorders, 4th edition [DSM-IV] criteria for a hypomanic or manic episode)
  • 2. Consent to participate in the trial
  • 3. Aged 16 or over
  • 4. Current depressive episode requiring new pharmacological treatment (either as add-on therapy or as a change of treatment)
  • 5. Quick Inventory of Depressive Symptomatology Self-Report (QIDS-SR16) Score >= 14
  • Please note that, as of 15/09/2008, inclusion criterion 1. Diagnosis of Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) bipolar disorder type I or II (assessed using the Mini-International Neuropsychiatric Interview [MINI]) has been replaced with 1. Primary diagnosis of bipolar disorder type I or II (based on Diagnostic and Statistical Manual of Mental Disorders, 4th edition [DSM-IV] criteria for a hypomanic or manic episode)
  • For the randomised phase:
  • 1. Able to tolerate quetiapine at a dose of at least 150 mg/day
  • 2. Uncertainty whether quetiapine plus lamotrigine would be more effective than quetiapine monotherapy
  • 3. Acceptable adherence to quetiapine (>90%) and to self-report SMS text-messages satisfactory
  • 4. QIDS-SR16 score of >=11 on day of randomisation
  • 5. Willing to accept random allocation of treatments
  • 6. In the opinion of the investigator, not currently experiencing manic or mixed episode

排除标准

  • Current exclusion criteria as of 15/09/2008:
  • 1. Definite indications or contraindications to lamotrigine, quetiapine or folic acid (Including pregnancy or planned pregnancy)
  • 2. New course of specific psychosocial intervention started in the past four weeks
  • 3. First appointment for specific psychosocial intervention booked within the next 14 weeks
  • 4. Primary diagnosis of schizophrenia
  • Plus, for women of child-bearing potential:
  • 5. Currently breast feeding or not using adequate contraception
  • Current exclusion criteria as of 28/04/2008:
  • 1. Definite indications or contraindications to lamotrigine, quetiapine or folic acid (Including pregnancy or planned pregnancy)
  • 2. New course of specific psychosocial intervention started in the past four weeks
  • 3. First appointment for specific psychosocial intervention booked within the next 14 weeks
  • 4. Currently meeting criteria for (hypo)mania (based on MINI)
  • 5. Currently meeting criteria for schizophrenia
  • 6. Eight or more mood episodes in the past year
  • Plus, for women of child-bearing potential:
  • 7. Not using adequate contraception
  • Initial exclusion criteria:
  • 1. Definite indications or contraindications to lamotrigine, quetiapine or folic acid (Including pregnancy or planned pregnancy)
  • 2. New course of structured psychotherapy started in the past four weeks
  • 3. First appointment for structured psychotherapy booked within the next 14 weeks
  • 4. Currently meeting criteria for (hypo)mania (based on MINI)
  • 5. Eight or more mood episodes in the past year
  • Plus, for women of child-bearing potential:
  • 6. Not using adequate contraception

研究者

发起方
niversity of Oxford (UK)

相似试验

Comparative Evaluation of QUEtiapine-Lamotrigine... | 临床试验